p19INK4d mRNA and protein expression as new prognostic factors in ovarian cancer patients.

MLA

Felisiak-Golabek, Anna, et al. “P19INK4d MRNA and Protein Expression as New Prognostic Factors in Ovarian Cancer Patients.” Cancer Biology & Therapy, vol. 14, no. 10, Oct. 2013, pp. 973–81. EBSCOhost, https://doi.org/10.4161/cbt.25966.

APA

Felisiak-Golabek, A., Dansonka-Mieszkowska, A., Rzepecka, I. K., Szafron, L., Kwiatkowska, E., Konopka, B., Podgorska, A., Rembiszewska, A., & Kupryjanczyk, J. (2013). p19INK4d mRNA and protein expression as new prognostic factors in ovarian cancer patients. Cancer Biology & Therapy, 14(10), 973–981. https://doi.org/10.4161/cbt.25966

Chicago

Felisiak-Golabek, Anna, Agnieszka Dansonka-Mieszkowska, Iwona K. Rzepecka, Lukasz Szafron, Ewa Kwiatkowska, Bozena Konopka, Agnieszka Podgorska, Alina Rembiszewska, and Jolanta Kupryjanczyk. 2013. “P19INK4d MRNA and Protein Expression as New Prognostic Factors in Ovarian Cancer Patients.” Cancer Biology & Therapy 14 (10): 973–81. doi:10.4161/cbt.25966.